Treating Depression In Children Could Lead To Poor Bone Development

by Medindia Content Team on  November 19, 2004 at 5:10 PM General Health News
RSS Email Print This Page Comment
Font : A-A+

Treating Depression In Children Could Lead To Poor Bone Development
A common class of drugs prescribed to children with depression may have an adverse effect on bone growth, according to a new study. Researchers say they found a reduction in bone mass and size in mice given fluoxetine, more commonly known as Prozac. Fluoxetine is the only prescription antidepressant currently approved by the FDA for children and adolescents.

Other preliminary studies show the use of selective serotonin-reuptake inhibitors, like fluoxetine, has been linked to increased bone loss at the hip in elderly women, decreased bone density in men, and decreased skeletal growth in children.

In conclusion researchers say more research is needed on the use of these drugs in children since bone development early in life is believed to determine lifelong skeletal health.

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Adolescence Depression Depression Height and Weight-Kids Stress Relief Through Alternative Medicine Andropause / Male Menopause Pregnancy and Complications Bereavement Holistic Management for Depression Tourette Syndrome Dealing with Menopause symptoms through lifestyle changes 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive